151 related articles for article (PubMed ID: 16002025)
1. Efficacy of dose and contingency management procedures in LAAM-maintained cocaine-dependent patients.
Oliveto A; Poling J; Sevarino KA; Gonsai KR; McCance-Katz EF; Stine SM; Kosten TR
Drug Alcohol Depend; 2005 Aug; 79(2):157-65. PubMed ID: 16002025
[TBL] [Abstract][Full Text] [Related]
2. A comparison between low-magnitude voucher and buprenorphine medication contingencies in promoting abstinence from opioids and cocaine.
Gross A; Marsch LA; Badger GJ; Bickel WK
Exp Clin Psychopharmacol; 2006 May; 14(2):148-56. PubMed ID: 16756418
[TBL] [Abstract][Full Text] [Related]
3. A randomized, open-label trial comparing methadone and Levo-Alpha-Acetylmethadol (LAAM) in maintenance treatment of opioid addiction.
Wolstein J; Gastpar M; Finkbeiner T; Heinrich C; Heitkamp R; Poehlke T; Scherbaum N
Pharmacopsychiatry; 2009 Jan; 42(1):1-8. PubMed ID: 19153939
[TBL] [Abstract][Full Text] [Related]
4. A comparison of levomethadyl acetate, buprenorphine, and methadone for opioid dependence.
Johnson RE; Chutuape MA; Strain EC; Walsh SL; Stitzer ML; Bigelow GE
N Engl J Med; 2000 Nov; 343(18):1290-7. PubMed ID: 11058673
[TBL] [Abstract][Full Text] [Related]
5. Predictors of outcome in LAAM, buprenorphine, and methadone treatment for opioid dependence.
Marsch LA; Stephens MA; Mudric T; Strain EC; Bigelow GE; Johnson RE
Exp Clin Psychopharmacol; 2005 Nov; 13(4):293-302. PubMed ID: 16366759
[TBL] [Abstract][Full Text] [Related]
6. Six-month trial of bupropion with contingency management for cocaine dependence in a methadone-maintained population.
Poling J; Oliveto A; Petry N; Sofuoglu M; Gonsai K; Gonzalez G; Martell B; Kosten TR
Arch Gen Psychiatry; 2006 Feb; 63(2):219-28. PubMed ID: 16461866
[TBL] [Abstract][Full Text] [Related]
7. Dose-response analysis of opioid cross-tolerance and withdrawal suppression during LAAM maintenance.
Houtsmuller EJ; Walsh SL; Schuh KJ; Johnson RE; Stitzer ML; Bigelow GE
J Pharmacol Exp Ther; 1998 May; 285(2):387-96. PubMed ID: 9580575
[TBL] [Abstract][Full Text] [Related]
8. Effects of voucher-based intervention on abstinence and retention in an outpatient treatment for cocaine addiction: a randomized controlled trial.
Garcia-Rodriguez O; Secades-Villa R; Higgins ST; Fernandez-Hermida JR; Carballo JL; Errasti Perez JM; Al-halabi Diaz S
Exp Clin Psychopharmacol; 2009 Jun; 17(3):131-8. PubMed ID: 19586227
[TBL] [Abstract][Full Text] [Related]
9. Relative potency of levo-alpha-acetylmethadol and methadone in humans under acute dosing conditions.
Eissenberg T; Stitzer ML; Bigelow GE; Buchhalter AR; Walsh SL
J Pharmacol Exp Ther; 1999 May; 289(2):936-45. PubMed ID: 10215673
[TBL] [Abstract][Full Text] [Related]
10. Effect of LAAM dose on opiate use in opioid-dependent patients. A pilot study.
Oliveto AH; Farren C; Kosten TR
Am J Addict; 1998; 7(4):272-82. PubMed ID: 9809131
[TBL] [Abstract][Full Text] [Related]
11. Desipramine and contingency management for cocaine and opiate dependence in buprenorphine maintained patients.
Kosten T; Oliveto A; Feingold A; Poling J; Sevarino K; McCance-Katz E; Stine S; Gonzalez G; Gonsai K
Drug Alcohol Depend; 2003 Jun; 70(3):315-25. PubMed ID: 12757969
[TBL] [Abstract][Full Text] [Related]
12. Effects of LAAM and methadone utilization in an opiate agonist treatment program.
Valdivia JF; Khattak S
Mt Sinai J Med; 2000; 67(5-6):398-403. PubMed ID: 11064490
[TBL] [Abstract][Full Text] [Related]
13. Effect of PTSD diagnosis and contingency management procedures on cocaine use in dually cocaine- and opioid-dependent individuals maintained on LAAM: a retrospective analysis.
Mancino MJ; McGaugh J; Feldman Z; Poling J; Oliveto A
Am J Addict; 2010; 19(2):169-77. PubMed ID: 20163389
[TBL] [Abstract][Full Text] [Related]
14. Induction with levomethadyl acetate: safety and efficacy.
Jones HE; Strain EC; Bigelow GE; Walsh SL; Stitzer ML; Eissenberg T; Johnson RE
Arch Gen Psychiatry; 1998 Aug; 55(8):729-36. PubMed ID: 9707384
[TBL] [Abstract][Full Text] [Related]
15. Effects of varying the monetary value of voucher-based incentives on abstinence achieved during and following treatment among cocaine-dependent outpatients.
Higgins ST; Heil SH; Dantona R; Donham R; Matthews M; Badger GJ
Addiction; 2007 Feb; 102(2):271-81. PubMed ID: 17222282
[TBL] [Abstract][Full Text] [Related]
16. Levo-alpha-acetylmethadol (LAAM) versus methadone maintenance: 1-year treatment retention, outcomes and status.
Anglin MD; Conner BT; Annon J; Longshore D
Addiction; 2007 Sep; 102(9):1432-42. PubMed ID: 17697277
[TBL] [Abstract][Full Text] [Related]
17. Levo-alpha-acetylmethadol (LAAM) versus methadone: treatment retention and opiate use.
Longshore D; Annon J; Anglin MD; Rawson RA
Addiction; 2005 Aug; 100(8):1131-9. PubMed ID: 16042643
[TBL] [Abstract][Full Text] [Related]
18. Buprenorphine treatment for opioid dependence: the relative efficacy of daily, twice and thrice weekly dosing.
Marsch LA; Bickel WK; Badger GJ; Jacobs EA
Drug Alcohol Depend; 2005 Feb; 77(2):195-204. PubMed ID: 15664721
[TBL] [Abstract][Full Text] [Related]
19. A randomized trial of long-term reinforcement of cocaine abstinence in methadone-maintained patients who inject drugs.
Silverman K; Robles E; Mudric T; Bigelow GE; Stitzer ML
J Consult Clin Psychol; 2004 Oct; 72(5):839-54. PubMed ID: 15482042
[TBL] [Abstract][Full Text] [Related]
20. HIV risk behaviors during pharmacologic treatment for opioid dependence: a comparison of levomethadyl acetate [corrected] buprenorphine, and methadone.
Lott DC; Strain EC; Brooner RK; Bigelow GE; Johnson RE
J Subst Abuse Treat; 2006 Sep; 31(2):187-94. PubMed ID: 16919747
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
